Sichenzia Ross Ference Carmel LLP Represents Brookline Capital Markets in the $6.4 Million Initial Public Offering of OS Therapies Incorporated

New York, NY – August 2, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) represented Brookline Capital Markets, a division of Arcadia Securities LLC, in the $6.4 million initial public offering of OS Therapies Incorporated (NYSE: OSTX), a clinical stage oncology company focused on the treatment of osteosarcoma and other solid tumors in children and young adults.

Brookline Capital Markets acted as the sole book-running manager for the offering.

The SRFC team was led by partners Marc Ross and Tom Rose, and associate Benjamin Sklar.